Target intelligence / Profile preview

Family with sequence similarity 153 member D, pseudogene (FAM153DP)

Target
FAM153DP
Molecular classification
Other (Pseudogene)
01

Overview

FAM153DP (family with sequence similarity 153 member D, pseudogene) is annotated as a pseudogene and does not produce a functional protein[1][3][7]. Pseudogenes are DNA sequences similar to known genes but have lost their protein-coding potential due to mutations, such as premature stop codons or frameshifts. While traditionally considered nonfunctional "junk DNA," recent research demonstrates that some pseudogenes can have regulatory functions at the RNA level, influencing gene expression through mechanisms such as acting as microRNA decoys or being processed into small interfering RNAs[5][7]. FAM153DP has no described protein product, biological activity, or disease relevance in available public resources. There is no evidence for direct clinical or pharmacological relevance, nor any documentation that it serves as a marker or target for therapy[1][3][5][7]. In summary, FAM153DP is a pseudogene, not a functional molecular target, and does not fit canonical therapeutic target categories. All drug, disease, biomarker, and mechanism entries should be considered as null for structured data purposes.

Other names
FAM153DPFamily with sequence similarity 153 member D, pseudogeneNCBI Gene: 102724062
02

Mechanism of action

None reported for this entity. Mechanisms relating to pseudogene function typically involve RNA-mediated regulation rather than classical biochemical activity.

03

Biological functions

Pseudogenes generally do not encode functional proteins. Some can have regulatory roles at the RNA level, such as acting as miRNA decoys or sources of regulatory noncoding RNAs, but specific biological functions for FAM153DP are not documented in the available resources.Regulatory noncoding RNA (general pseudogene function)Other
04

Disease associations

There are no direct disease roles reported for FAM153DP. In general, some pseudogenes are involved in cancer or gene expression regulation, but no specific attribution to FAM153DP could be found.
05

Safety considerations

None documented, as pseudogenes are not targets of pharmacological intervention.
06

Interacting drugs

None reported. Pseudogenes are not typically targeted by drugs and there are no known drugs interacting with FAM153DP.
07

Biomarkers

None known or described for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on Family with sequence similarity 153 member D, pseudogene (FAM153DP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Family with sequence similarity 153 member D, pseudogene (FAM153DP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call